Status:
COMPLETED
Arimidex Bone Mass Index and Oral Bisphosphonates
Lead Sponsor:
Hellenic Breast Surgeons Society
Conditions:
Breast Cancer
Bone Density
Eligibility:
FEMALE
18-80 years
Brief Summary
To investigate the management of bone health in postmenopausal women with early breast cancer (BCA) scheduled to receive anastrozole. Postmenopausal women with hormone receptor-positive early BCA are ...
Eligibility Criteria
Inclusion
- Postmenopausal women
- ER and or PgR positive breast cancer
- Completed Surgery and =/- chemotherapy
Exclusion
- metastases
- history of fractures
- HRT or SERMs
- Liver or kidney disfunction
Key Trial Info
Start Date :
May 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2007
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT00809484
Start Date
May 1 2004
End Date
February 1 2007
Last Update
January 6 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hellenic Breast Surgeons Society
Athens, Greece, 11527